Orphenadrine Citrate
NDC 25021-651, orphenadrine citrate, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-651
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090585
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ORPHENADRINE CITRATE30 mg/mL
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-651-02 | 25021065102 | 10 VIAL in 1 CARTON (25021-651-02) / 2 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c8d8596a-b81f-4b83-a2f3-a55922ca4a82Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-651NADAC price for package 25021065102
GET /v1/drugs/nadac/25021065102
Use it
Look up 25021-651 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-651. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.